REG - Oxford Nanopore Tech - Publication of Annual Report and Notice of AGM

Oxford Nanopore TechnologiesAnnouncement

Wed 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250430:nRSd6702Ga&default-theme=true

RNS Number : 6702G  Oxford Nanopore Technologies plc  30 April 2025

30 April 2025

Oxford Nanopore Technologies plc

(the "Company")

Publication of 2024 Annual Report and Notice of Annual General Meeting

 

Oxford Nanopore Technologies plc (LSE:ONT), the company behind a new
generation of nanopore-based sequencing technology, today announces that it
has published its Annual Report and Accounts for the year ended 31 December
2024 and its Notice of Annual General Meeting 2025.

In compliance with Listing Rule 9.6.1, copies of the following documents have
been submitted to the National Storage Mechanism and will shortly be available
for inspection at:

https://www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism
(https://www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism)
 

 

·      Annual Report and Accounts for the year ended 31
December 2024 ("2024 ARA"); and

·      Notice of Annual General Meeting 2025 ("2025 AGM Notice").

Printed copies of the 2024 ARA and 2025 AGM Notice, together with the Form of
Proxy for use in connection with the 2025 Annual General Meeting, have been
posted to shareholders who have elected to receive hard copies. Electronic
copies of the 2024 ARA and 2025 AGM Notice are available on the Investor
Relations section of the Company's website
at https://nanoporetech.com/about-us/investors.
(https://nanoporetech.com/about-us/investors)

The 2025 Annual General Meeting will be held at the Company's offices at
Gosling Building, Edmund Halley Road, Oxford Science Park, Oxford, OX4 4DQ at
10:30am on Wednesday, 4 June 2025. Details including how shareholders can vote
by proxy and ask questions in advance of the meeting can be found in the 2025
AGM Notice. The Board also encourages all shareholders to submit a proxy vote
in advance of the AGM. We recommend voting online via www.shareview.co.uk
(http://www.shareview.co.uk) by logging in, selecting 'View' on the 'My
Investments' page and then click on the link to vote and follow the on-screen
instructions.

 

Explanatory note

For the purposes of complying with the Disclosure and Transparency Rules, the
2024 ARA being submitted to the National Storage Mechanism contains the
following regulated information in unedited form:

·      The principal risks and uncertainties facing the Company;

·      The Directors' responsibility statement made in respect of the
Financial Statements and Directors' Report contained in the 2024 ARA; and

·      A statement regarding related party transactions.

-ENDS-

For further information please contact:

cosec@nanoporetech.com (mailto:cosec@nanoporetech.com)

ir@nanoporetech.com (mailto:ir@nanoporetech.com)

 

About Oxford Nanopore Technologies plc:

Oxford Nanopore Technologies' goal is to bring the widest benefits to society
through enabling the analysis of anything, by anyone, anywhere. The company
has developed a new generation of nanopore-based sensing technology for
faster, information rich, accessible and affordable molecular analysis. The
first application is DNA/RNA sequencing, and the technology is in development
for the analysis of other types of molecules including proteins. The
technology is used in more than 125 countries to understand and characterise
the biology of humans and diseases such as cancer, plants, animals, bacteria,
viruses, and whole environments. Oxford Nanopore Technologies products are
intended for molecular biology applications and are not intended for
diagnostic purposes. For more information, please
visit: https://nanoporetech.com/ (https://nanoporetech.com/)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOABUGDSBGDDGUC